U.S. Markets close in 1 hr 36 mins
  • S&P 500

    3,672.95
    +51.32 (+1.42%)
     
  • Dow 30

    29,908.80
    +270.16 (+0.91%)
     
  • Nasdaq

    12,387.72
    +188.98 (+1.55%)
     
  • Russell 2000

    1,841.97
    +22.16 (+1.22%)
     
  • Crude Oil

    44.47
    -0.87 (-1.92%)
     
  • Gold

    1,818.30
    +37.40 (+2.10%)
     
  • Silver

    24.11
    +1.52 (+6.74%)
     
  • EUR/USD

    1.2055
    +0.0121 (+1.0127%)
     
  • 10-Yr Bond

    0.9340
    +0.0900 (+10.66%)
     
  • Vix

    20.42
    -0.15 (-0.73%)
     
  • GBP/USD

    1.3422
    +0.0091 (+0.6792%)
     
  • USD/JPY

    104.3700
    +0.0460 (+0.0441%)
     
  • BTC-USD

    18,926.94
    -472.83 (-2.44%)
     
  • CMC Crypto 200

    372.07
    -7.79 (-2.05%)
     
  • FTSE 100

    6,384.73
    +118.54 (+1.89%)
     
  • Nikkei 225

    26,787.54
    +353.92 (+1.34%)
     

A Look Into Healthcare Sector Value Stocks

Benzinga Insights
·2 min read

What Defines a Value Stock?

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.

Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:

  1. Lexicon Pharmaceuticals (NASDAQ: LXRX) - P/E: 4.94

  2. Opiant Pharmaceuticals (NASDAQ: OPNT) - P/E: 4.86

  3. Bio-Rad Laboratories (NASDAQ: BIO) - P/E: 7.83

  4. Five Star Senior Living (NASDAQ: FVE) - P/E: 3.85

  5. Cronos Group (NASDAQ: CRON) - P/E: 2.48

Lexicon Pharmaceuticals’s earnings per share for Q2 sits at -0.65, whereas in Q1, they were at -0.63. Lexicon Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Most recently, Opiant Pharmaceuticals reported earnings per share at -0.05, whereas in Q1 earnings per share sat at -0.4. Opiant Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Bio-Rad Laboratories has reported Q2 earnings per share at 1.61, which has decreased by 15.71% compared to Q1, which was 1.91. Bio-Rad Laboratories does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Most recently, Five Star Senior Living reported earnings per share at 0.1, whereas in Q1 earnings per share sat at -0.55. Five Star Senior Living does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Most recently, Cronos Group reported earnings per share at -0.19, whereas in Q1 earnings per share sat at 0.2. Cronos Group does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.